These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36941788)

  • 1. Combining MYD88 L265P mutation detection and clonality determination on CSF cellular and cell-free DNA improves diagnosis of primary CNS lymphoma.
    Bravetti C; Degaud M; Armand M; Sourdeau E; Mokhtari K; Maloum K; Osman J; Verrier P; Houillier C; Roos-Weil D; Soussain C; Choquet S; Hoang-Xuan K; Le Garff-Tavernier M; Denis JA; Davi F
    Br J Haematol; 2023 Jun; 201(6):1088-1096. PubMed ID: 36941788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study.
    Ferreri AJM; Calimeri T; Lopedote P; Francaviglia I; Daverio R; Iacona C; Belloni C; Steffanoni S; Gulino A; Anghileri E; Diffidenti A; Finardi A; Gagliardi F; Anzalone N; Nonis A; Furlan R; De Lorenzo D; Terreni MR; Martinelli V; Sassone M; Foppoli M; Angelillo P; Guggiari E; Falini A; Mortini P; Filippi M; Tarantino V; Eoli M; Ciceri F; Doglioni C; Tripodo C; Locatelli M; Cangi MG; Ponzoni M
    Br J Haematol; 2021 May; 193(3):497-505. PubMed ID: 33620087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid detection of the MYD88 L265P mutation for pre- and intra-operative diagnosis of primary central nervous system lymphoma.
    Yamaguchi J; Ohka F; Kitano Y; Maeda S; Motomura K; Aoki K; Takeuchi K; Nagata Y; Hattori H; Tsujiuchi T; Motomura A; Nishikawa T; Kibe Y; Shinjo K; Kondo Y; Saito R
    Cancer Sci; 2023 Jun; 114(6):2544-2551. PubMed ID: 36859777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of circulating tumor DNA in plasma of patients with primary CNS lymphoma by digital droplet PCR.
    Zhong Y; Tan GW; Bult J; Veltmaat N; Plattel W; Kluiver J; Enting R; Diepstra A; van den Berg A; Nijland M
    BMC Cancer; 2024 Apr; 24(1):407. PubMed ID: 38566053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid biopsy of cerebrospinal fluid for MYD88 L265P mutation is useful for diagnosis of central nervous system lymphoma.
    Yamagishi Y; Sasaki N; Nakano Y; Matushita Y; Omura T; Shimizu S; Saito K; Kobayashi K; Narita Y; Kondo A; Shiokawa Y; Nagane M; Ichimura K
    Cancer Sci; 2021 Nov; 112(11):4702-4710. PubMed ID: 34523186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic evidence implies that primary and relapsed tumors arise from common precursor cells in primary central nervous system lymphoma.
    Hattori K; Sakata-Yanagimoto M; Kusakabe M; Nanmoku T; Suehara Y; Matsuoka R; Noguchi M; Yokoyama Y; Kato T; Kurita N; Nishikii H; Obara N; Takano S; Ishikawa E; Matsumura A; Muratani M; Hasegawa Y; Chiba S
    Cancer Sci; 2019 Jan; 110(1):401-407. PubMed ID: 30353605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of droplet digital PCR in liquid biopsies: A highly sensitive technique for MYD88 p.(L265P) detection in cerebrospinal fluid.
    Hiemcke-Jiwa LS; Minnema MC; Radersma-van Loon JH; Jiwa NM; de Boer M; Leguit RJ; de Weger RA; Huibers MMH
    Hematol Oncol; 2018 Apr; 36(2):429-435. PubMed ID: 29210102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary diffuse large B-cell lymphoma of the central nervous system identified with CSF biomarkers.
    Loser V; Segot A; de Leval L; Bisig B; Brouland JP; Hewer E; Barcena C; Hottinger AF; Pot C
    BMC Neurol; 2024 Jul; 24(1):250. PubMed ID: 39039441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of the
    Zorofchian S; Lu G; Zhu JJ; Duose DY; Windham J; Esquenazi Y; Ballester LY
    Front Oncol; 2018; 8():382. PubMed ID: 30294590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aqueous Humor-Derived MYD88 L265P Mutation Analysis in Vitreoretinal Lymphoma: A Potential Less Invasive Method for Diagnosis and Treatment Response Assessment.
    Demirci H; Rao RC; Elner VM; Demirci FY; Axenov L; Betz B; Behdad A; Brown N
    Ophthalmol Retina; 2023 Feb; 7(2):189-195. PubMed ID: 35952929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single B-Cell Genomic Analyses Differentiate Vitreoretinal Lymphoma from Chronic Inflammation.
    Tan WJ; Wang MM; Castagnoli PR; Tang T; Chan ASY; Lim TS
    Ophthalmology; 2021 Jul; 128(7):1079-1090. PubMed ID: 33221324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of disease-specific MYD88 mutations in circulating DNA in primary central nervous system lymphoma.
    Hattori K; Sakata-Yanagimoto M; Suehara Y; Yokoyama Y; Kato T; Kurita N; Nishikii H; Obara N; Takano S; Ishikawa E; Matsumura A; Hasegawa Y; Chiba S
    Cancer Sci; 2018 Jan; 109(1):225-230. PubMed ID: 29151258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Driver Mutational Hot Spots in Blood-Derived Cell-Free DNA of Patients with Primary Central Nervous System Lymphoma Obtained before Intracerebral Biopsy.
    Montesinos-Rongen M; Brunn A; Tuchscherer A; Borchmann P; Schorb E; Kasenda B; Altmüller J; Illerhaus G; Ruge MI; Maarouf M; Büttner R; Hansmann ML; Hallek M; Prinz M; Siebert R; Deckert M
    J Mol Diagn; 2020 Oct; 22(10):1300-1307. PubMed ID: 32745612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Detection Rate of
    Watanabe J; Natsumeda M; Okada M; Kobayashi D; Kanemaru Y; Tsukamoto Y; Oishi M; Kakita A; Fujii Y
    JCO Precis Oncol; 2019 Dec; 3():1-13. PubMed ID: 35100686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of cerebrospinal fluid liquid biopsy in distinguishing CNS lymphoma from cerebrospinal infectious/demyelinating diseases.
    Iriyama C; Murate K; Iba S; Okamoto A; Goto N; Yamamoto H; Kato T; Mihara K; Miyama T; Hattori K; Kajiya R; Okamoto M; Mizutani Y; Yamada S; Tsukamoto T; Hirose Y; Mutoh T; Watanabe H; Tomita A
    Cancer Med; 2023 Aug; 12(16):16972-16984. PubMed ID: 37501501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MyD88 Mutation in Elderly Predicts Poor Prognosis in Primary Central Nervous System Lymphoma: Multi-Institutional Analysis.
    Takano S; Hattori K; Ishikawa E; Narita Y; Iwadate Y; Yamaguchi F; Nagane M; Akimoto J; Oka H; Tanaka S; Sakata M; Matsuda M; Yamamoto T; Chiba S; Matsumura A
    World Neurosurg; 2018 Apr; 112():e69-e73. PubMed ID: 29258950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of digital PCR for MYD88
    Chen K; Ma Y; Ding T; Zhang X; Chen B; Guan M
    Exp Ther Med; 2020 Jul; 20(1):301-308. PubMed ID: 32536998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Diagnosis of Vitreoretinal Lymphoma by Detection of MYD88 Mutation in Aqueous Humor With Ultrasensitive Droplet Digital Polymerase Chain Reaction.
    Hiemcke-Jiwa LS; Ten Dam-van Loon NH; Leguit RJ; Nierkens S; Ossewaarde-van Norel J; de Boer JH; Roholl FF; de Weger RA; Huibers MMH; de Groot-Mijnes JDF; Kuiper JJW
    JAMA Ophthalmol; 2018 Oct; 136(10):1098-1104. PubMed ID: 30027272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of the MYD88
    Wu YY; Jia MN; Cai H; Qiu Y; Zhou DB; Li J; Cao XX
    Ann Hematol; 2020 Aug; 99(8):1763-1769. PubMed ID: 32577844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring of MYD88 L265P mutation by droplet digital polymerase chain reaction for prediction of early relapse in a patient with Bing-Neel syndrome.
    Shikata H; Kihara H; Kaneko M; Matsukage S; Hattori K
    Int J Hematol; 2021 Apr; 113(4):586-591. PubMed ID: 33222046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.